Novonesis A/S

LSE:0Q4U Stock Report

Market Cap: DKK 181.2b

Novonesis Valuation

Is 0Q4U undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0Q4U when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0Q4U (DKK390.1) is trading below our estimate of fair value (DKK395.97)

Significantly Below Fair Value: 0Q4U is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0Q4U?

Key metric: As 0Q4U is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0Q4U. This is calculated by dividing 0Q4U's market cap by their current earnings.
What is 0Q4U's PE Ratio?
PE Ratio85.9x
Earnings€282.79m
Market Cap€24.30b

Price to Earnings Ratio vs Peers

How does 0Q4U's PE Ratio compare to its peers?

The above table shows the PE ratio for 0Q4U vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average25.2x
CRDA Croda International
29.7x15.1%UK£4.8b
JMAT Johnson Matthey
24x28.4%UK£2.6b
VCT Victrex
24.4x37.8%UK£749.6m
TET Treatt
22.7x15.3%UK£256.6m
0Q4U Novonesis
85.9x1.1%DKK 181.2b

Price-To-Earnings vs Peers: 0Q4U is expensive based on its Price-To-Earnings Ratio (85.9x) compared to the peer average (25.2x).

Price to Earnings Ratio vs Industry

How does 0Q4U's PE Ratio compare vs other companies in the European Chemicals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
0Q4U 85.9xIndustry Avg. 17.1xNo. of Companies11PE01224364860+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0Q4U is expensive based on its Price-To-Earnings Ratio (85.9x) compared to the European Chemicals industry average (17.9x).

Price to Earnings Ratio vs Fair Ratio

What is 0Q4U's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0Q4U PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio85.9x
Fair PE Ratio15.8x

Price-To-Earnings vs Fair Ratio: 0Q4U is expensive based on its Price-To-Earnings Ratio (85.9x) compared to the estimated Fair Price-To-Earnings Ratio (15.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0Q4U forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentDKK 390.10
DKK 486.88
+24.8%
10.9%DKK 586.00DKK 364.00n/a16
Nov ’25DKK 431.00
DKK 488.00
+13.2%
11.1%DKK 560.00DKK 360.00n/a15
Oct ’25DKK 482.79
DKK 487.50
+1.0%
11.0%DKK 560.00DKK 360.00n/a16
Sep ’25DKK 466.31
DKK 464.99
-0.3%
11.1%DKK 540.00DKK 360.00n/a16
Aug ’25DKK 440.76
DKK 458.43
+4.0%
10.6%DKK 540.00DKK 360.00n/a16
Jul ’25DKK 424.24
DKK 449.81
+6.0%
10.7%DKK 540.00DKK 350.00n/a16
Jun ’25DKK 408.60
DKK 437.35
+7.0%
9.1%DKK 500.00DKK 350.00n/a14
May ’25DKK 385.87
DKK 430.86
+11.7%
9.2%DKK 500.00DKK 350.00n/a14
Apr ’25DKK 405.13
DKK 419.78
+3.6%
9.6%DKK 500.00DKK 340.00n/a14
Mar ’25DKK 388.97
DKK 408.29
+5.0%
8.5%DKK 460.00DKK 326.00n/a14
Feb ’25DKK 361.99
DKK 397.38
+9.8%
8.2%DKK 450.00DKK 326.00n/a13
Jan ’25DKK 371.20
DKK 386.62
+4.2%
8.1%DKK 430.00DKK 326.00n/a13
Dec ’24DKK 355.52
DKK 376.54
+5.9%
9.0%DKK 430.00DKK 326.00n/a13
Nov ’24DKK 313.85
DKK 361.77
+15.3%
11.9%DKK 430.00DKK 275.00DKK 431.0013
Oct ’24DKK 285.79
DKK 374.00
+30.9%
12.6%DKK 460.00DKK 275.00DKK 482.7913
Sep ’24DKK 297.03
DKK 373.36
+25.7%
11.4%DKK 460.00DKK 300.00DKK 466.3114
Aug ’24DKK 335.95
DKK 385.64
+14.8%
11.3%DKK 460.00DKK 300.00DKK 440.7614
Jul ’24DKK 317.90
DKK 393.50
+23.8%
13.4%DKK 520.00DKK 300.00DKK 424.2414
Jun ’24DKK 337.83
DKK 396.36
+17.3%
12.6%DKK 520.00DKK 320.00DKK 408.6014
May ’24DKK 351.92
DKK 395.64
+12.4%
12.2%DKK 510.00DKK 320.00DKK 385.8714
Apr ’24DKK 350.90
DKK 387.64
+10.5%
12.8%DKK 510.00DKK 320.00DKK 405.1314
Mar ’24DKK 341.40
DKK 391.93
+14.8%
13.5%DKK 520.00DKK 320.00DKK 388.9714
Feb ’24DKK 356.06
DKK 393.71
+10.6%
13.8%DKK 520.00DKK 320.00DKK 361.9914
Jan ’24DKK 350.80
DKK 415.80
+18.5%
13.4%DKK 520.00DKK 330.00DKK 371.2015
Dec ’23DKK 428.49
DKK 410.19
-4.3%
15.1%DKK 540.00DKK 330.00DKK 355.5216
Nov ’23DKK 393.76
DKK 423.94
+7.7%
14.8%DKK 540.00DKK 330.00DKK 313.8516

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Navigator Company

€2.6b

Manufactures and markets pulp and paper products worldwide.

0KLO

€3.68

7D

5.1%

1Y

-2.2%

Elkem

NOK 11.4b

Engages in the provision of advanced material solutions worldwide.

0SFN

NOK 17.97

7D

-0.6%

1Y

-3.5%

TFF Group

€682.9m

Manufactures and distributes barrels and wood products for the aging of wines and alcohols in France, rest of Europe, the United States, Asia, and internationally.

0IH4

€31.50

7D

7.5%

1Y

-25.4%